YOLFTbeta
India Globalization Capital Inc

India Globalization Capital Inc

IGC · AMEX · Healthcare / Biotechnology

0.18USD-0.00 (-2.44%)

Price History

Full chart

Market Stats

Previous Close0.1845
Open0.19
Day Range0.17 – 0.19
52-Week Range0.24 – 0.45
Volume508.50K
Market Cap29.20M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
Beta0.49
50-Day Avg0.2786
200-Day Avg0.2866

About

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Ram Mukunda
  • Employees70
  • Headquarters10224 Falls Road, Potomac, MD, United States, 20854, USA
  • Websitehttps://igcpharma.com

Leadership

  • Mr. Ram MukundaFounder, President, CEO & Director · b. 1959
  • Ms. Claudia GrimaldiVP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director · b. 1972
  • Benysh Qureshi Esq., M.B.A.Director of Operations
  • Mr. Rohit Goel CPA, M.B.A.Director of Accounting & Senior Director · b. 1994
  • Susana SalgarSales Manager

Financials

Income Statement

Currency: USD2006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue210.58K-765.00K2.19M35.34M17.90M4.07M4.20M8.03M2.27M7.68M6.37M580.37K2.19M5.12M4.07M898.00K397.00K911.00K1.34M1.27M1.19M
Growth (%)--463.28%+386.01%+1515.13%-49.35%-77.24%+3.09%+91.19%-71.69%+237.88%-17.10%-90.88%+277.86%+133.29%-20.41%-77.95%-55.79%+129.47%+47.64%-5.50%-6.69%
Cost of Revenue--1.84M28.05M15.67M3.92M4.82M6.50M1.89M7.10M5.52M362.13K2.11M4.98M3.96M1.25M203.00K1.07M612.00K652.00K834.00K
Gross Profit210.58K-765.00K346.52K7.29M2.23M159.26K-618.00K1.53M381.60K579.69K843.29K218.24K81.52K132.00K115.00K-349.00K194.00K-158.00K733.00K619.00K352.00K
Gross Margin100.00%100.00%15.84%20.62%12.44%3.91%-14.71%19.09%16.79%7.55%13.24%37.60%3.72%2.58%2.82%-38.86%48.87%-17.34%54.50%48.70%29.68%
Operating Expense73.68K47341.52K3.48M6.22M8.07M6.89M4.02M2.91M4.92M3.75M2.27M1.87M4.78M6.98M8.38M15.62M11.41M10.53M8.06M10.55M
Operating Income136.90K-765.05K5.00K3.81M-3.99M-7.91M-7.51M-2.48M-2.53M-4.34M-2.91M-2.05M-1.79M-4.64M-6.86M-8.72M-15.43M-11.57M-9.80M-7.45M-10.20M
Operating Margin65.01%100.01%0.23%10.78%-22.30%-194.13%-178.86%-30.93%-111.22%-56.54%-45.64%-353.91%-81.58%-90.75%-168.57%-971.49%-3886.15%-1270.14%-728.48%-585.84%-860.29%
EBITDA136.90K2.44M4.37M4.36M-5.74M-14.73M-5.77M-1.54M-2.04M-3.61M-1.89M-1.22M-1.74M-4.58M-6.72M-8.33M-14.37M-10.85M-12.36M-6.66M-6.22M
EBITDA Margin65.01%-318.46%199.54%12.33%-32.05%-361.54%-137.31%-19.17%-89.71%-47.01%-29.70%-210.04%-79.16%-89.60%-165.03%-927.95%-3618.39%-1190.89%-919.18%-523.76%-524.79%
Net Income91.90K1.52M-5.21M-522.00K-4.79M-20.24M-7.75M-2.25M-3.02M-4.61M-2.81M-1.87M-1.79M-4.10M-7.32M-8.81M-15.02M-11.51M-13.00M-7.12M-6.55M
Net Income Margin43.64%-198.43%-238.35%-1.48%-26.76%-496.83%-184.57%-28.04%-133.00%-60.08%-44.10%-321.69%-81.44%-80.08%-179.64%-981.18%-3782.37%-1263.01%-966.54%-560.27%-552.11%
R&D------0000137.00K114.00K137.00K1.26M1.01M929.00K2.33M3.46M3.77M3.65M5.19M
R&D as % of Total Revenue------0.00%0.00%0.00%0.00%2.15%19.64%6.25%24.55%24.83%103.45%586.90%379.91%280.52%287.57%437.86%
Interest Expense0103.92K1.94B1.75M1.22M1.40M984.02K419.44K291.52K286.33K213.93K223.46K30.74K000412.00K65.00K---
Interest Expense % of Total Revenue0.00%-13.58%88878.43%4.96%6.82%34.24%23.43%5.22%12.83%3.73%3.36%38.50%1.40%0.00%0.00%0.00%103.78%7.14%---

Balance Sheet

Currency: USD2006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets65.93M70.69M67.63M51.83M35.37M18.16M25.26M19.25M17.73M20.33M18.86M11.28M10.85M34.47M28.98M35.87M26.83M17.18M9.90M8.75M9.19M
Total Liabilities15.76M17.76M26.75M13.97M9.22M10.87M9.44M4.28M3.59M5.58M4.91M3.93M2.79M893.00K2.45M3.06M2.94M2.27M2.58M2.42M3.06M
Total Equity50.17M52.92M27.33M23.60M26.15M6.67M14.84M14.97M13.63M14.23M13.48M7.35M8.06M33.57M26.54M32.80M23.89M14.91M7.32M6.33M6.12M
Cash2.21K1.17M8.40M2.13M842.92K1.58M562.95K1.06M1.03M824.49K1.49M538.03K1.66M25.61M7.26M14.55M10.46M3.20M1.20M405.00K207.00K
Total Debt870.00K2.66M9.85M6.44M5.51M4.82M2.23M2.25M2.22M3.48M2.82M2.64M2.23M50.00K624.00K1.07M611.00K481.00K345.00K241.00K926.00K
Net Debt867.79K1.49M1.45M4.31M4.67M3.24M1.67M1.18M1.20M2.65M1.33M2.11M569.00K-25.56M-6.63M-13.47M-9.85M-2.71M-853.00K-164.00K719.00K

Cash Flow

Currency: USD2006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow-95.21K-1.56M-8.57M-8.11M-2.96M-2.63M-5.02M178.20K-1.74M-2.58M-157.70K-1.39M-1.93M-3.33M-8.68M-10.80M-7.46M-7.05M-5.20M-4.79M-5.94M
Investing Cash Flow-65.62M-274.23K57.26M2.89M--44.70K4.67M-74.70K3.08K-518.09K-183.42K-241.35K-657.11K-260.00K-9.55M3.39M-742.00K-235.00K-317.00K-442.00K-192.00K
Financing Cash Flow65.72M3.00M-41.38M-155.63K4.18M3.41M-625.76K414.34K1.74M2.90M1.01M707.56K3.71M27.60M-59.00K14.69M4.14M100.00K3.52M4.45M5.93M
Capital Expenditure0017.00K2.49M1.20M285.44K5.48K326.08K8.48K76.53K122.19K145.68K200.56K60.00K4.47M1.59M771.00K619.00K515.00K482.00K164.00K
Free Cash Flow-95.21K-1.56M-8.59M-10.61M-4.15M-2.92M-5.03M-147.88K-1.75M-2.66M-279.89K-1.54M-2.13M-3.39M-13.14M-12.39M-8.23M-7.67M-5.71M-5.28M-6.11M
Dividends Paid------0000000--------
FCF to OCF100.00%100.00%100.20%130.73%140.56%110.83%100.11%-82.99%100.49%102.96%177.48%110.47%110.39%101.80%151.47%114.74%110.33%108.78%109.91%110.05%102.76%
Dividend Paid to FCF------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateJun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Aug 18, 2008Nov 17, 2008Feb 18, 2009Jun 3, 2009Aug 12, 2009Nov 12, 2009Feb 10, 2010Jul 14, 2010Nov 22, 2010Feb 22, 2011Jun 30, 2011Aug 18, 2011Nov 21, 2011Feb 16, 2012Jun 30, 2012Aug 20, 2012Dec 31, 2012Feb 13, 2013Jun 30, 2013Aug 16, 2013Nov 11, 2013Feb 18, 2014Jun 30, 2014Aug 15, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Nov 11, 2015Feb 12, 2016Jun 30, 2016Aug 16, 2016Nov 21, 2016Feb 21, 2017Jun 30, 2017Aug 18, 2017Nov 17, 2017Feb 20, 2018Jun 21, 2018Aug 3, 2018Oct 16, 2018Feb 12, 2019Jun 14, 2019Aug 9, 2019Nov 6, 2019Feb 10, 2020Jun 17, 2020Aug 19, 2020Nov 20, 2020Feb 12, 2021Jun 14, 2021Aug 11, 2021Oct 29, 2021Feb 10, 2022Jun 22, 2022Aug 5, 2022Nov 1, 2022Feb 14, 2023Jun 30, 2023Aug 10, 2023Nov 9, 2023Feb 14, 2024Jun 24, 2024Aug 7, 2024Nov 12, 2024Feb 14, 2025Jun 27, 2025Aug 5, 2025Nov 14, 2025Feb 18, 2026May 15, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate-------------0.75-0.390.10-0.17-0.230.000.010.010.010.000.01--0.030.000.02-0.07-0.060.00-0.03--0.00---0.00---0.00---0.00--------------------0.00-0.05-0.04-0.04-0.03-0.03-0.03-0.02-0.03-0.02-0.02-0.02-0.02-0.02
EPS Actual0.310.300.250.230.030.01-0.09-6.031.450.08-1.98-0.15-0.52-0.50-4.50-0.87-0.60-1.20-0.43-0.40-0.40-0.70-0.14-0.100.050.10-0.09-0.09-0.09-0.04-0.12-0.06-0.05-0.09-0.03-0.04-0.02-0.08-0.02-0.02-0.00-0.04-0.02-0.01-0.01-0.02-0.02-0.02-0.03-0.03-0.04-0.03-0.03-0.04-0.08-0.05-0.04-0.06-0.07-0.04-0.09-0.05-0.13-0.05-0.05-0.04-0.08-0.04-0.05-0.05-0.40-0.03-0.02-0.02-0.01-0.01-0.02-0.02-0.02-0.03-
Surprise--------------166.67%-1053.85%-970.00%-252.94%-421.74%--4100.00%-4100.00%-7100.00%--1100.00%-433.33%--550.00%-28.57%33.33%--100.00%------------------------------------0.00%-25.00%-900.00%0.00%33.33%33.33%50.00%50.67%0.00%0.00%0.00%-50.00%-
Timing---------------After-hoursPre-marketAfter-hours-After-hoursAfter-hoursPre-market-After-hours-Pre-market-After-hoursPre-marketPre-market-Pre-market-------After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap29.20M
Enterprise Value30.31M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales26.40
Price / Book4.82
EPS-0.06
Book Value0.06
Revenue (TTM)1.11M
Gross Profit (TTM)511.00K
EBITDA-7.52M
Profit Margin0.00%
Operating Margin-1050.57%
Return on Equity-83.34%
Return on Assets-50.31%
Shares Outstanding103.38M
Shares Float89.37M
Beta0.49
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 6.00
  • Strong Buy
    2

Stock Splits

  • Apr 19, 20131:10